FDA Approves Inluriyo for Advanced Breast Cancer
Approval is for adults with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer
Elinzanetant Safe, Effective for Moderate-to-Severe Vasomotor Symptoms
Benefits seen in frequency and severity, as well as menopause-related quality of life
Nonoptimal Levels of Traditional Risk Factors Almost Universal Before CVD
In both men and women, prevalence of one or more traditional risk factor before CVD was >99 percent across age groups
Kennedy Says FDA Reviewing Safety of Abortion Pill Mifepristone
Poor Mental Health Outcomes More Likely With Hyperemesis Gravidarum
Greatest relative risks seen for Wernicke encephalopathy, refeeding syndrome, postpartum depression, eating disorders
Tylenol Refutes Old Post as Pregnancy Safety Debate Resurfaces
Doctors stress untreated fever can pose greater risks to mothers and babies
Adding Molecular Breast Imaging to DBT Beneficial for Dense Breasts
Adding MBI to digital breast tomosynthesis provided incremental cancer detection rates of 6.7 and 3.5 percent at year 1 and year 2, respectively
5.7 Million More U.S. Women Than Expected Were Childless in 2024
10 percent more women were aged 20 to 39 years in 2024 than 2006, but proportion who had never had a child increased by 45 percent
Guidelines Developed for Postmastectomy Radiation Therapy
PMRT indicated for most with node-positive breast cancer and select patients with node-negative disease
Remote Perioperative Telemonitoring Beneficial After Cancer Surgery
Patients in the RPM care arm had a 6 percent greater functional recovery rate
